COVID and CLL: An Update

From our recent CLL Global Research Foundation Town Hall featuring CLL Global President, Dr. William Wierda, and Dr. Constantine Tam from Monash University in Melbourne.

2024 CLL Research Highlights From ASCO and EHA

From our September 2024 CLL Global Research Foundation town hall featuring CLL Global President, Dr. William Wierda, and Dr. Erin Parry from Dana-Farber Cancer Institute. CLL patient advocate Jeff Folloder moderated the event.

The Latest COVID Recommendations for CLL Patients

From our September 2024 CLL Global Research Foundation town hall featuring CLL Global President, Dr. William Wierda, and Dr. Erin Parry from Dana-Farber Cancer Institute. CLL patient advocate Jeff Folloder moderated the event.

Research Update | Richter’s Transformation

From our September 2024 CLL Global Research Foundation town hall featuring CLL Global President, Dr. William Wierda, and Dr. Erin Parry from Dana-Farber Cancer Institute. CLL patient advocate Jeff Folloder moderated the event.

What Are Current First-Line CLL Treatment Approaches?

From our September 2024 CLL Global Research Foundation town hall featuring CLL Global President, Dr. William Wierda, and Dr. Erin Parry from Dana-Farber Cancer Institute. CLL patient advocate Jeff Folloder moderated the event.

Where Is Advanced CLL Research Being Conducted?

From our September 2024 CLL Global Research Foundation town hall featuring CLL Global President, Dr. William Wierda, and Dr. Erin Parry from Dana-Farber Cancer Institute. CLL patient advocate Jeff Folloder moderated the event.

Current Research Studies to Treat Relapsed/Refractory CLL

From our September 2024 CLL Global Research Foundation town hall featuring CLL Global President, Dr. William Wierda, and Dr. Erin Parry from Dana-Farber Cancer Institute. CLL patient advocate Jeff Folloder moderated the event.

How Will CLL Treatment and Research Evolve in the Future?

From our September 2024 CLL Global Research Foundation town hall featuring CLL Global President, Dr. William Wierda, and Dr. Erin Parry from Dana-Farber Cancer Institute. CLL patient advocate Jeff Folloder moderated the event.

What Is the Risk of Secondary Cancers in CLL Patients?

From our September 2024 CLL Global Research Foundation town hall featuring CLL Global President, Dr. William Wierda, and Dr. Erin Parry from Dana-Farber Cancer Institute. CLL patient advocate Jeff Folloder moderated the event.